Pacira BioSciences
PCRX
PCRX
208 hedge funds and large institutions have $1.69B invested in Pacira BioSciences in 2018 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 69 increasing their positions, 76 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.81% less ownership
Funds ownership: 99.83% → 98.02% (-1.8%)
16% less capital invested
Capital invested by funds: $2.01B → $1.69B (-$325M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
208
Holding in Top 10
3
Calls
$31.3M
Puts
$7.81M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$16M | |
| 3 | +$13.7M | |
| 4 |
Renaissance Technologies
New York
|
+$12.1M |
| 5 |
D.E. Shaw & Co
New York
|
+$9M |
Top Sellers
| 1 | -$97.8M | |
| 2 | -$13.7M | |
| 3 | -$12.6M | |
| 4 |
Millennium Management
New York
|
-$8.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.64M |